Saturday 17 October 2026
Export BRKR’s income statement to Excel — free account
Bruker Corporation
BRKR Healthcare Medical Devices
Bruker Corporation’s revenue for fiscal 2025 (year ended December 2025) was $3.4 billion, up 2.08% from fiscal 2024. In the quarter to June 2026, revenue grew 5.15%, EPS fell 920.0%, free cash flow grew 28.6% and total debt fell 25.1%, each against the same quarter a year earlier. Dividend growth for ten consecutive years, revenue growth for five.
54.80
1.74
−3.08%
Follow BRKR
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 3 | 5 |
| (1.11%) | (1.05%) | (1.69%) | (5.07%) | ||
| (0.38%) | (0.37%) | (0.60%) | (1.73%) | ||
ROIC |
0.96% | 1.05% | 0.73% | (0.47%) | |
Return on Tangible Assets |
(1.30%) | (1.34%) | (2.48%) | (6.16%) | |
Average Days of Receivables |
58.47 | 57.88 | 57.28 | 56.94 | |
Free Cash Flow per Share |
(0.07) | 0.29 | 0.34 | 0.62 | |
Free Cash Flow |
(10.60) | 43.30 | 51.30 | 93.90 | |
Capital Expenditures |
(104.90) | (90.80) | (89.00) | (96.50) | |
| Other line items | |||||
Cash ROIC |
(0.22%) | 0.93% | 1.20% | 2.13% | |
Accounts Receivable Turnover |
6.31 | 6.19 | 6.40 | 6.55 | |
Accounts Payable Turnover |
8.82 | 8.26 | 7.37 | 8.46 | |
Inventory Turnover |
1.50 | 1.72 | 1.69 | 1.60 | |
Average Days of Payables |
37.04 | 42.39 | 51.91 | 38.97 | |
Days of Inventory on Hand |
240.36 | 214.94 | 216.33 | 218.02 | |
Tax Rate |
(3.25) | (1.33) | (1.23) | 1.80 | |
Research and Development Expense of Revenue |
11.63% | 11.50% | 11.55% | 11.24% | |
Selling, General and Administrative Expense of Revenue |
27.53% | 27.54% | 27.85% | 27.74% | |
Share Based Compensation of Revenue |
0.00% | 2.22% | 0.00% | 0.00% | |
Operating CF/Net income |
(3.98) | (5.96) | (3.85) | (1.78) | |
Depreciation/Fixed assets |
0.29 | 0.30 | 0.32 | 0.32 | |
Capex/Depreciation |
(0.49) | (0.41) | (0.39) | (0.42) | |
Revenue per Share |
22.65 | 22.64 | 22.72 | 22.98 | |
Operating CF per Share |
0.62 | 0.88 | 0.92 | 1.25 | |
Capex per Share |
(0.69) | (0.60) | (0.58) | (0.63) | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 |
Columns are period end dates